Commentary: GSK, Pfizer and GE shift away from diversification in latest round of health-care deals
GlaxoSmithKline, Pfizer and General Electric all made key announcements Wednesday signaling that health-care companies are shifting to focus their businesses on their greatest strengths and abandoning the diversification strategies that have characterized health care for the past two decades.